ACACA and fatty liver disease: Several authors have concluded that de novo fatty acid synthesis via acetyl-CoA carboxylase (Acaca) and fatty acid synthase (Fasn) may play a role in the onset of hepatic steatosis related to CLA supplementation [21, 22].